Inventor · disambiguated record
Drew Dudgeon
Also filed as: DUDGEON DREW
5 granted patents·3 pending applications·36 citations·filing 2016–2025
76Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0197US10179819B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2016·Granted Jan 15, 2019·25 cites·12 claims
- 0295US11155633B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2018·Granted Oct 26, 2021·9 cites·24 claims
- 0391US11787867B2Anti-GITR antibodies and uses thereofREGENERON PHARMA·Filed 2021·Granted Oct 17, 2023·2 cites·24 claims
- 0481US2025282891A1Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0577US12331127B2Therapeutic uses of anti-GITR antibodiesREGENERON PHARMA·Filed 2023·Granted Jun 17, 2025·0 cites·55 claims
- 0676US12344677B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2021·Granted Jul 1, 2025·0 cites·28 claims
- 0766US2024158515A1Anti-fgfr3 antibodies and antigen-binding fragments and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0865US2024173426A1Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytesREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Drew Dudgeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →